Immune mechanisms in malaria: new insights in vaccine development
- 6 February 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 19 (2), 168-178
- https://doi.org/10.1038/nm.3083
Abstract
Early data emerging from the first phase 3 trial of a malaria vaccine are raising hopes that a licensed vaccine will soon be available for use in endemic countries, but given the relatively low efficacy of the vaccine, this needs to be seen as a major step forward on the road to a malaria vaccine rather than as arrival at the final destination. The focus for vaccine developers now moves to the next generation of malaria vaccines, but it is not yet clear what characteristics these new vaccines should have or how they can be evaluated. Here we briefly review the epidemiological and immunological requirements for malaria vaccines and the recent history of malaria vaccine development and then put forward a manifesto for future research in this area. We argue that rational design of more effective malaria vaccines will be accelerated by a better understanding of the immune effector mechanisms involved in parasite regulation, control and elimination.Keywords
This publication has 130 references indexed in Scilit:
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Malaria impairs resistance to Salmonella through heme- and heme oxygenase–dependent dysfunctional granulocyte mobilizationNature Medicine, 2011
- Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparumNature, 2011
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibodyNature Communications, 2011
- Systems biology of vaccination for seasonal influenza in humansNature Immunology, 2011
- Superior Antimalarial Immunity after Vaccination with Late Liver Stage-Arresting Genetically Attenuated ParasitesCell Host & Microbe, 2011
- Plasmodium immunomicsInternational Journal for Parasitology, 2010
- Genetics of antigenic variation in Plasmodium falciparumCurrent Genetics, 2009
- MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccinesJournal of Immunological Methods, 2009
- Chapter 1 Strain Theory of MalariaAdvances in Parasitology, 2008